Long follow-up of patients with locally advanced cervical cancer treated with concomitant chemobrachyradiotherapy with cisplatin and ifosfamide followed by consolidation chemotherapy

International Journal of Gynecological Cancer

Volumn 25, Issue 2, 2015, Pages 315-319

  Miše, Branka Petrić ^a   Jelavić, Tihana Boraska ^a   Strikic, Ante ^a   Hrepić, Darijo ^a   Tomić, Krešimir ^b   Hamm, Wolfgang ^c   Tomić, Snježana ^a   Prskalo, Tomislav ^a   Vrdoljak, Eduard ^a  

^a UNIVERSITY HOSPITAL SPLIT   (Croatia)

^b UNIVERSITY OF MOSTAR   (Bosnia and Herzegovina)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Cervical cancer; Chemobrachyradiotherapy; Cisplatin; Ifosfamide

Indexed keywords

CISPLATIN; IFOSFAMIDE; MESNA; ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; AGE; AGED; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CANCER THERAPY; CHEMOBRACHYRADIOTHERAPY; COLITIS; CONSOLIDATION CHEMOTHERAPY; CYSTITIS; CYSTOVAGINAL FISTULA; DISEASE FREE SURVIVAL; DRUG DOSE REDUCTION; EXTERNAL BEAM RADIOTHERAPY; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HUMAN; LEUKOPENIA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; OVERALL SURVIVAL; POOR GENERAL CONDITION; PRIORITY JOURNAL; PROCTITIS; RADIATION DOSE; RADIATION RESPONSE; RECTOVAGINAL FISTULA; SKIN FIBROSIS; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; URETER OBSTRUCTION; UTERINE CERVIX CARCINOMA; VAGINITIS; ADVERSE EFFECTS; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; DISEASE COURSE; MIDDLE AGED; MORTALITY; PATHOLOGY; SURVIVAL; UTERINE CERVICAL NEOPLASMS;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; CONSOLIDATION CHEMOTHERAPY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IFOSFAMIDE; MIDDLE AGED; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS;

EID: 84925871695     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0000000000000336     Document Type: Article

References (29)

1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available at: http://globocan.iarc.fr. Accessed January 24, 2014.
2. Whitney CW, Sause W, Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatinversus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol. 1999;17:1339-1348.
3. Peters WA, Liu PY, Barret RJ 2nd, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000;18:1606-1613.
4. Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 1999;340:1137-1143.
5. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340:1144-1153.
6. Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 1999;340:1154-1161.
7. Rose PG. Concurrent chemoradiation for locally advanced carcinoma of the cervix: where are we in 2006? Ann Oncol. 2006;17:x224-x229.
8. Vrdoljak E, Omrcen T, Novaković ZS, et al. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix-final results of a prospective phase II-study. Gynecol Oncol. 2006;103:494-499.
9. Kuehnle H, Meerpohl HG, Eiermann W, et al. Neoadjuvant therapy for cervical cancer. Semin Oncol. 1992;19:94-98.
10. Bloss JD. Chemotherapy for advanced or recurrent carcinoma of the cervix. Curr Oncol Rep. 2001;3:33-40.
11. Tonkin KS, Kelland LR, Steel GG. Chemotherapy-radiation interactions in human cervix carcinoma xenografts. Br J Cancer. 1988;58:738-741.
12. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365:1687-1717.
13. André T, Boni C, Navarro M, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol. 2009;27:3109-3116.
14. Vrdoljak E, Prskalo T, Omrčen T, et al. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: results of a phase II study. Int J Radiat Oncol Biol Phys. 2005;61:824-829.
15. Lanciano RM, Won M, Coia LR, et al. Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies. Int J Radiat Oncol Biol Phys. 1991;20:667-676.
16. Green JA, Kirwan JJ, Tierney J, et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev. 2005;(3) Art. No.: CD002225.
17. Lara PC, Gracia-Puche JL, Pedraza V. Cisplatin-ifosfamide as neoadjuvant chemotherapy in stage IIIB cervical uterine squamous-cell carcinoma. Cancer Chemother Pharmacol. 1990;26:36-38.
18. Lee MY, Wu HG, Kim K, et al. Concurrent radiotherapy with paclitaxel/carboplatin chemotherapy as a definitive treatment for squamous cell carcinoma of the uterine cervix. Gynecol Oncol. 2007;104:95-99.
19. Ferrandina G, Ercoli A, Fagotti A, et al. Completion surgery after concomitant chemoradiation in locally advanced cervical cancer: a comprehensive analysis of pattern of postoperative complications. Ann Surg Oncol. 2014;21:1692-1699.
20. Candelaria M, Chanona-Vilchis J, Cetina L, et al. Prognostic significance of pathological response after neoadjuvant chemotherapy or chemoradiation for locally advanced cervical carcinoma. Int Semin Surg Oncol. 2006;3:3
21. Dueñas-González A, Zarbá JJ, Patel F, et al. Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patientswith stage IIB to IVA carcinoma of the cervix. J Clin Oncol. 2011;29:1678-1685.
22. Eifel PJ, Winter K, Morris M, et al. Pelvic irradiationwith concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer An update of Radiation Therapy Oncology Group Trial (RTOG) 90-01. J Clin Oncol. 2004;22:872-880.
23. Forrest JL, Ackerman I, Barbera L, et al. Patient outcome study of concurrent chemoradiation, external beam radiotherapy, and high-dose rate brachytherapy in locally advanced carcinoma of the cervix. Int J Gynecol Cancer. 2010;20:1074-1078.
24. Kato S, Ohno T, Thephamongkhol K, et al. Long-term follow-up results of a multi-institutional phase 2 study of concurrent chemoradiation therapy for locally advanced cervical cancer in east and southeast Asia. Int J Radiat Oncol Biol Phys. 2013;87:100-105.
25. Clinical Trials.gov [Internet]. US National Institutes of Health, 2014. Available at: http://clinicaltrials.gov/show/NCT01414608. Accessed October 10, 2014.
26. Clinical Trials.gov [Internet]. US National Institutes of Health, 2014. Available at: http://clinicaltrials.gov/show/NCT01566240. Accessed October 10, 2014.
27. NCI Funded Research portfolio [Internet]. National Cancer Institute; 2014. Available at: http://fundedresearch.cancer.gov/nciportfolio/. Accessed August 10, 2014.
28. Clinical Trials.gov [Internet]. US National Institutes of Health, 2014. Available at: http://clinicaltrials.gov/ct2/results?term=breast&recr=Open&rslt=&type=&cond=&intr=&titles=&outc=&spons=&lead=&id=&state1=&cntry1=&state2=&cntry2=&state3=&cntry3=&locn=&gndr=&rcv-s=&rcv-e=&lup-s=&lup-e=. Accessed August 31, 2014.
29. Clinical Trials.gov [Internet]. US National Institutes of Health, 2014. Available at: http://clinicaltrials.gov/ct2/results?term=uterine+cervix&recr=Open&rslt=&type=&cond=&intr=&titles=&outc=&spons=&lead=&id=&state1=&cntry1=&state2=&cntry2=&state3=&cntry3=&locn=&gndr=&rcv-s=&rcv-e=&lup-s=&lup-e=. Accessed August 31, 2014.